GSK gets SEC approval for scheme of arrangement to delist from the Nigerian Exchange
![](/images/markets/ngse/Glaxosmithkline.jpg)
The Board of GlaxoSmithKline Consumer Nigeria Plc (GSK) has announced that the Company has received the Securities and Exchange Commission’s formal approval of its scheme of arrangement which will result in delisting from the Nigerian Exchange Limited (NGX).